Lowering Costs for Patients: The Health of the Biosimilar Market

House 119th · April 08, 2025 at 2:00 PM

Longworth House Office Building, Room 1100 · Scheduled

Ways and Means Committee › Health Subcommittee · 19 members ↓

Buchanan, Vern R-FL Chair

Smith, Adrian R-NE

Tenney, Claudia R-NY

Miller, Carol D. R-WV

Moore, Blake D. R-UT

Kustoff, David R-TN

Murphy, Gregory F. R-NC

Steube, W. Gregory R-FL

Fitzpatrick, Brian K. R-PA

Hern, Kevin R-OK

Kelly, Mike R-PA

Doggett, Lloyd D-TX Ranking

Evans, Dwight D-PA

Boyle, Brendan F. D-PA

Chu, Judy D-CA

Davis, Danny K. D-IL

Thompson, Mike D-CA

Horsford, Steven D-NV

Sánchez, Linda T. D-CA

Witnesses (4)

Debra Patt

President

Community Oncology Alliance

Statement·Truth in Testimony·Biography

Colin Edgerton

Director

Articularis Healthcare Group

Statement·Truth in Testimony·Biography

Craig Burton

Executive Director

Biosimilars Council

Statement·Truth in Testimony·Biography

Aaron Kesselheim

Professor of Medicine

Harvard University

Statement·Truth in Testimony·Biography

Free access to AI-generated transcripts

Speaker identification, synchronized video playback, full-text search, and deep linking — all free.